Cargando…
Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis
[Image: see text] The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders. D3R-selective compounds with high affinity and varying efficacies have been discovered, providing critical research tools for cell-based studies that have been translated to in v...
Autores principales: | Keck, Thomas M., John, William S., Czoty, Paul W., Nader, Michael A., Newman, Amy Hauck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516313/ https://www.ncbi.nlm.nih.gov/pubmed/25826710 http://dx.doi.org/10.1021/jm501512b |
Ejemplares similares
-
The Role of Adenosine Receptors in Psychostimulant Addiction
por: Ballesteros-Yáñez, Inmaculada, et al.
Publicado: (2018) -
Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors
por: Hersey, Melinda, et al.
Publicado: (2023) -
Binge eating and psychostimulant addiction
por: Blanco-Gandia, M Carmen, et al.
Publicado: (2021) -
Role of Microglia in Psychostimulant Addiction
por: Machado da Silva, Maria Carolina, et al.
Publicado: (2023) -
Differences in addictive beliefs in people with psychostimulant addiction and in opioid addicts
por: Yan, Y., et al.
Publicado: (2022)